How dependent is India on Heparin API imports?

India imports $0.09 bn, mostly from China. Its Critical Manufacturing Dependency Index is 64.87/100 (High), with a localisation potential of 58.

Heparin API

High dependencyBuild-nowPharmaceuticals & APIsReasoned estimateHS 3001.90

$0.09 bnAnnual import

21%Indian capability

5,398Supplier concentration (HHI)

₹3,140 crTo localise

Why India imports it. Reasoned estimate: India has limited domestic capacity for heparin api; sector trade patterns indicate continued import reliance.

Why it matters. Strategic dependency within pharma value chain; affects downstream manufacturing competitiveness.

Can India localise it? Partial

Where it comes from. China (65%), South Korea (23%), Vietnam (12%).

Scorecard

The ten indices

CMDI 64.87Dependency

LPI 58Localisation potential

IAI 66.25Investment attractiveness

SRI 63.99Supply risk

SCI 51.5Supply-chain complexity

TRI 43.75Technology readiness

IMI 66.5Industrial multiplier

NSRI 57.25National-security relevance

EPI 65.25Export potential

ICGI 60.57Capability gap

Intelligence

Related signals

Sources

Primary references

pharmaceuticals.gov.in ↗

Confidence: Reasoned estimate. Reasoned estimate derived from sector trade patterns and HS code classification; specific company/number values are modelled. Part of Techadyant Labs' Critical Manufacturing Dependencies (Edition I).